儿童早期注射喉成形术的安全性与疗效
该回顾性研究纳入17例单侧声带活动不良(UVFI)发病6个月内接受注射喉成形术(IL)的儿童,评估其安全性与疗效。结果显示IL安全,无不良事件,71.4%需饮食调整的患儿经口摄入改善,但先天性心脏缺陷者更可能需要胃造瘘。
要点
- 儿童UVFI早期IL安全,无气道不良事件。
- IL可减少误吸风险并改善经口摄入。
- 先天性心脏病患儿术后需胃造瘘风险更高。
核心结论
- 儿童UVFI早期注射喉成形术安全,可减少误吸并改善经口摄入。
研究设计与样本
- 回顾性研究纳入2006至2017年间17例UVFI发病6个月内接受IL的儿童,中位年龄8个月。
主要发现
- 16例术前接受吞咽评估,14例因误吸风险需饮食调整,其中10例(71.4%)IL后经口摄入改善。
- 5例因严重口运动不协调行胃造瘘。
- 先天性心脏缺陷患儿既往手术更多(3.0±0.4 vs 1.2±0.2,P=.006),更可能需要胃造瘘(45% vs 0%,P=.05)。
- 无患者发生IL相关不良事件,无需要插管的气道症状。
关键数值与推荐
- 共17例患儿,男10例(58.8%),中位年龄8个月(四分位距2个月至11.5岁)。
- 11例(64.7%)UVFI发生于先天性心脏缺陷修复术后。
临床怎么用
- 对儿童UVFI可考虑早期IL以降低误吸风险并促进经口喂养。
- 先天性心脏缺陷患儿术后需密切评估喂养,警惕胃造瘘需求。
局限性
- 回顾性设计、样本量小(17例)、证据等级4级。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The major morbidity of unilateral vocal fold immobility (UVFI) in children is due to aspiration. Early injection laryngoplasty (IL) can decrease aspiration risk; however, this has not been well studied in pediatric otolaryngology. This study examines safety and efficacy of early IL in children. METHODS: Retrospective review of pediatric patients undergoing IL with any injectate between 2006 and 2017 within 6 months of onset of UVFI. Outcomes included diet pre- and postprocedure, incidence of aspiration-related sequelae, and adverse events. RESULTS: Seventeen patients met eligibility criteria. Ten (58.8%) were males. Median age was 8 months (interquartile range, 2 months-11.5 years). All patients had prior surgeries; the largest subgroup (11 patients, 64.7%) had UVFI after repair of a congenital cardiac defect. Other causes included thyroidectomy, high vagal injury, and prolonged intubation. Sixteen patients underwent swallowing evaluation prior to IL and 14 patients required dietary modifications due to aspiration risk. Consistency and/or volume of oral intake improved after IL in 10 (71.4%) of them. Five patients underwent gastrostomy tube placement for significant oromotor incoordination. Children with congenital cardiac defects had more previous surgeries (3.0 ± 0.4 vs. 1.2 ± 0.2, P = .006) and were more likely to require G-tube placement due to poor feeding despite IL (45% vs. 0%, P = .05). No patients experienced adverse events due to IL; in particular, none experienced airway symptoms requiring intubation. CONCLUSION: Early IL in pediatric patients with UVFI is safe and can reduce aspiration and improve oral intake. Future studies should elucidate patient subgroups most likely to benefit from this intervention. LEVEL OF EVIDENCE: 4 Laryngoscope, 129:1699-1705, 2019.
引用
- Bertelsen C, Jacobson L, Osterbauer B, et al. Safety and efficacy of Early injection laryngoplasty in pediatric patients. Laryngoscope. 2018. PMID: 30353553. doi:10.1002/lary.27436
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。